Periodontal and Cardiovascular Diseases Project
Primary Purpose
Periodontitis, Cardiovascular Diseases
Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Scaling and root planing
Supragingival prophylaxis
Sponsored by
About this trial
This is an interventional treatment trial for Periodontitis focused on measuring Periodontitis, Cardiovascular diseases, Bacteremia, Scaling and root planing, Flow-mediated dilation, carotid intima-media thickness, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans
Eligibility Criteria
Inclusion Criteria:
- (1) patients with established cardiovascular disease (unstable angina or stroke in the previous 3 to 12 months, and left ventricular ejection fraction ≥50%);
- (2) diagnosis of moderate to severe generalized periodontitis (PD>5mm and marginal bone loss >30% on at least 50% of the teeth, according to Tonetti et al. 2007);
- (3) presence of at least 3 teeth per quadrant.
Exclusion Criteria:
- (1) periodontal treatment in the previous year;
- (2) antibiotic intake in the previous 3 months;
- (3) smokers of ≥10 cigarettes per day;
- (4) pregnancy or breast feeding;
- (5) diabetes mellitus types I or II, with glycosylated hemoglobin values >7;
- (6) necrotizing periodontal diseases;
- (7) HIV infection;
- (8) chronic intake of NSAID
Sites / Locations
- Severo Ochoa HospitalRecruiting
- Faculty of dentistry, Complutense University Madrid
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Scaling and root planing
Supragingival prophylaxis
Arm Description
Two sessions of scaling and root planing under local anesthesia and oral antiseptics (clorhexidine 0.12% rinse),
Two sessions of supragingival prophylaxis under local anesthesia and an oral rinse with no antiseptic properties.
Outcomes
Primary Outcome Measures
Flow mediated dilation of the brachial artery
Endothelium-dependent vasodilatation of the brachial artery assessed by means of ultrasound imaging with the use of a 7-MHz linear probe and vessel diameter measurements. Dilatation was quantified as the change in percentage form a baseline measurement and a second measurement taken after 5 minutes of flow ischemia induced with a sphygmomanometer cuff placed on the forearm.
Secondary Outcome Measures
Carotid artery atherosclerosis
Intima-media thickness of the carotid artery assessed by means of ultrasound imaging with the use of a 7-MHz linear probe and an automated imaging software.
Periodontal pocket probing depth
Distance from the gingival margin to the base of the periodontal pocket, measured in 6 sites per tooth with a periodontal probe UNC-15.
Gingival recession
Distance from the gingival margin to the cementum-enamel junction, measured in 6 sites per tooth with a periodontal probe UNC-15.
Plaque index
Presence or absence of dental plaque around teeth, measured in 6 sites per tooth with a periodontal probe of the University of North Caroline (UNC)-15.
Bleeding on probing index
Presence or absence of bleeding 30 seconds after probing, measured in 6 sites per tooth with a periodontal probe UNC-15.
Suppuration on probing index
Presence or absence of gingival suppuration 30 seconds after probing, measured in 6 sites per tooth with a periodontal probe UNC-15.
Dental mobility
Presence of dental mobility, recorded according to Miller´s classification: 0: absence of mobility; 1: horizontal mobility <1mm; 2: horizontal mobility >1mm; 3: horizontal and vertical mobility.
Furcation lesions
Presence of periodontal attachment loss in the furcation area of multi-rooted teeth, recorded according to Lindhe´s classification: I: the probe penetrates less than one third of the horizontal dimension of the tooth; II: the probe penetrates more than one third of the horizontal dimension of the tooth; III: the probe penetrates through and through the tooth.
Number of present teeth
Number of teeth present in mouth.
Radiographic bone loss
Percentage of bone loss around teeth measured in an orthopantomography (<30%, 30-50%, >50%).
Bacteria in gingival crevicular fluid
Total counts (CFU/ml) and percentage of the flora of anaerobic bacteria present in gingival crevicular fluid. Samples will be processed by means of culture and quantitative polymerase chain reaction
Bacteria in blood samples
Total counts (CFU/ml) and percentage of the flora of anaerobic bacteria present in blood samples before and 10 minutes after the intervention. Samples will be processed by means of culture and quantitative polymerase chain reaction
Inflammatory biomarkers in serum samples
Levels of inflammatory biomarkers (interleukin 6, C reactive protein, e-selectin) and coagulation factors (d-dimer, prothrombin, fibrinogen, Von Willebrand factor) in serum, assessed by means of Luminex technique (Bio-Plex Pro-Assays kit).
Full Information
NCT ID
NCT02716259
First Posted
March 17, 2016
Last Updated
May 3, 2018
Sponsor
Universidad Complutense de Madrid
Collaborators
Instituto de Salud Carlos III
1. Study Identification
Unique Protocol Identification Number
NCT02716259
Brief Title
Periodontal and Cardiovascular Diseases Project
Official Title
Impact of Basic Periodontal Therapy in the Levels of Porphyromonas Gingivalis and Aggregatibacter Actinomycetemcomitans Subgingival and Its Association With Vascular Function
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Unknown status
Study Start Date
March 2016 (undefined)
Primary Completion Date
March 2020 (Anticipated)
Study Completion Date
March 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Complutense de Madrid
Collaborators
Instituto de Salud Carlos III
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to investigate whether basic periodontal therapy aim to reduce subgingival levels of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, has an impact on the vascular function of patients suffering from established cardiovascular disease.
Detailed Description
Design: randomized clinical trial, parallel design, double blinded.
Sample: 120 patients from the Cardiology Department of Hospital Severo Ochoa (Leganés, Madrid) suffering from established cardiovascular disease and generalized moderate/severe periodontitis. Sixty patients will be randomized to test group (scaling and root planing + systemic antimicrobials), and the other 60 subjects will be included in the control group, consisting on delayed periodontal treatment (supragingival prophylaxis + placebo).
Study visits:
Visit 1: screening Visit 2: baseline data collection (medical history, clinical variables, gingival crevicular fluid (GCF) samples, vascular function) Visit 3: panoramic x-ray, blood samples, randomization and first treatment session.
Visit 4: second treatment session. Visit 5: 24 hours inflammatory biomarkers assessment. Visit 6: 7 days inflammatory biomarkers assessment. Visit 7: 1 month follow up (clinical variables) Visit 8: 3 months follow up (clinical variables, vascular function) and supportive periodontal therapy.
Visit 9: 6 months follow up (clinical variables, GCF samples, inflammatory biomarkers, vascular function) and supportive periodontal therapy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontitis, Cardiovascular Diseases
Keywords
Periodontitis, Cardiovascular diseases, Bacteremia, Scaling and root planing, Flow-mediated dilation, carotid intima-media thickness, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Scaling and root planing
Arm Type
Experimental
Arm Description
Two sessions of scaling and root planing under local anesthesia and oral antiseptics (clorhexidine 0.12% rinse),
Arm Title
Supragingival prophylaxis
Arm Type
Placebo Comparator
Arm Description
Two sessions of supragingival prophylaxis under local anesthesia and an oral rinse with no antiseptic properties.
Intervention Type
Procedure
Intervention Name(s)
Scaling and root planing
Other Intervention Name(s)
Clorhexidine rinse (0.12%) (Perio-Aid, Dentaid, Spain)
Intervention Description
Two sessions of scaling and root planing under local anesthesia and clorhexidine rinse twice/day, 15 days
Intervention Type
Procedure
Intervention Name(s)
Supragingival prophylaxis
Other Intervention Name(s)
Sodium fluoride rinse (Fluor-Aid, Dentaid, Spain)
Intervention Description
Two sessions of scaling and root planing under local anesthesia and sodium fluoride rinse, twice/day, 15 days
Primary Outcome Measure Information:
Title
Flow mediated dilation of the brachial artery
Description
Endothelium-dependent vasodilatation of the brachial artery assessed by means of ultrasound imaging with the use of a 7-MHz linear probe and vessel diameter measurements. Dilatation was quantified as the change in percentage form a baseline measurement and a second measurement taken after 5 minutes of flow ischemia induced with a sphygmomanometer cuff placed on the forearm.
Time Frame
Day 0 (Baseline), Day 90, Day 180
Secondary Outcome Measure Information:
Title
Carotid artery atherosclerosis
Description
Intima-media thickness of the carotid artery assessed by means of ultrasound imaging with the use of a 7-MHz linear probe and an automated imaging software.
Time Frame
Day 0 (Baseline), Day 90, Day 180
Title
Periodontal pocket probing depth
Description
Distance from the gingival margin to the base of the periodontal pocket, measured in 6 sites per tooth with a periodontal probe UNC-15.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Gingival recession
Description
Distance from the gingival margin to the cementum-enamel junction, measured in 6 sites per tooth with a periodontal probe UNC-15.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Plaque index
Description
Presence or absence of dental plaque around teeth, measured in 6 sites per tooth with a periodontal probe of the University of North Caroline (UNC)-15.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Bleeding on probing index
Description
Presence or absence of bleeding 30 seconds after probing, measured in 6 sites per tooth with a periodontal probe UNC-15.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Suppuration on probing index
Description
Presence or absence of gingival suppuration 30 seconds after probing, measured in 6 sites per tooth with a periodontal probe UNC-15.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Dental mobility
Description
Presence of dental mobility, recorded according to Miller´s classification: 0: absence of mobility; 1: horizontal mobility <1mm; 2: horizontal mobility >1mm; 3: horizontal and vertical mobility.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Furcation lesions
Description
Presence of periodontal attachment loss in the furcation area of multi-rooted teeth, recorded according to Lindhe´s classification: I: the probe penetrates less than one third of the horizontal dimension of the tooth; II: the probe penetrates more than one third of the horizontal dimension of the tooth; III: the probe penetrates through and through the tooth.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Number of present teeth
Description
Number of teeth present in mouth.
Time Frame
Day 0 (baseline), Day 30, Day 90, Day 180
Title
Radiographic bone loss
Description
Percentage of bone loss around teeth measured in an orthopantomography (<30%, 30-50%, >50%).
Time Frame
Day 0 (baseline)
Title
Bacteria in gingival crevicular fluid
Description
Total counts (CFU/ml) and percentage of the flora of anaerobic bacteria present in gingival crevicular fluid. Samples will be processed by means of culture and quantitative polymerase chain reaction
Time Frame
Day 0 (baseline), Day 180
Title
Bacteria in blood samples
Description
Total counts (CFU/ml) and percentage of the flora of anaerobic bacteria present in blood samples before and 10 minutes after the intervention. Samples will be processed by means of culture and quantitative polymerase chain reaction
Time Frame
Day 1 (pre and post-therapy)
Title
Inflammatory biomarkers in serum samples
Description
Levels of inflammatory biomarkers (interleukin 6, C reactive protein, e-selectin) and coagulation factors (d-dimer, prothrombin, fibrinogen, Von Willebrand factor) in serum, assessed by means of Luminex technique (Bio-Plex Pro-Assays kit).
Time Frame
Day 1, Day 3, Day 10, Day 180
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
(1) patients with established cardiovascular disease (unstable angina or stroke in the previous 3 to 12 months, and left ventricular ejection fraction ≥50%);
(2) diagnosis of moderate to severe generalized periodontitis (PD>5mm and marginal bone loss >30% on at least 50% of the teeth, according to Tonetti et al. 2007);
(3) presence of at least 3 teeth per quadrant.
Exclusion Criteria:
(1) periodontal treatment in the previous year;
(2) antibiotic intake in the previous 3 months;
(3) smokers of ≥10 cigarettes per day;
(4) pregnancy or breast feeding;
(5) diabetes mellitus types I or II, with glycosylated hemoglobin values >7;
(6) necrotizing periodontal diseases;
(7) HIV infection;
(8) chronic intake of NSAID
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Molina, Mrs
Phone
0034647486381
Email
anamolinavillar@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Nagore Ambrosio, Mrs
Phone
0034628514105
Email
nagoreamb@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mariano Sanz, Professor
Organizational Affiliation
Faculty of Dentistry, Complutense University of Madrid
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
David Herrera, Professor
Organizational Affiliation
Faculty of Dentistry, Complutense University of Madrid
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Elena Figuero, Professor
Organizational Affiliation
Faculty of Dentistry, Complutense University of Madrid
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
María Molina, Doctor
Organizational Affiliation
Servicio de Cardiología, Hospital Universitario Severo Ochoa
Official's Role
Study Chair
Facility Information:
Facility Name
Severo Ochoa Hospital
City
Leganes
State/Province
Madrid
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
María Molina, Dr
Email
mariamovi@hotmail.com
First Name & Middle Initial & Last Name & Degree
Belén Terol, Physician
First Name & Middle Initial & Last Name & Degree
Carmen Rico, Physician
First Name & Middle Initial & Last Name & Degree
María Molina, Dr
Facility Name
Faculty of dentistry, Complutense University Madrid
City
Madrid
ZIP/Postal Code
28040
Country
Spain
Individual Site Status
Active, not recruiting
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
17329698
Citation
Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 2007 Mar 1;356(9):911-20. doi: 10.1056/NEJMoa063186. Erratum In: N Engl J Med. 2018 Jun 13;:null.
Results Reference
background
Learn more about this trial
Periodontal and Cardiovascular Diseases Project
We'll reach out to this number within 24 hrs